Wnt signaling in cancer.
Open accessThe DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.
Abstract
Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology. From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biology. This article summarizes the evidence supporting a role for Wnt signaling in human cancer. This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt. I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer. Finally, some emphasis is placed on laboratory research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, APC, as a gene that upregulates WNT signaling, is negatively correlated with the frequency of T cell infiltration [196,197,198].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429 · cited 1×
“Expression of the Wnt receptor FZD7 is characteristic of these types of breast cancer (Sorlie et al. 2003).”
BackgroundWnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · cited 1×
“The impact ofb-catenin knockdown in cancers without identifiable genetic lesions in Wnt signaling could relate to the purported role of Wnt in the establishment and maintenance of so-called cancer stem cells (CSCs) (Reya and Clevers 2005; Malanchi and Huelsken 2009).”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · cited 1×
“Consequently, inhibition of target gene activation in colorectal cancer cells expressing the dominant negative TCF4 resulted in their growth arrest (Tetsu and McCormick 1999; van de Wetering et al. 2002).”
BackgroundThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169 · cited 1×
“Paradoxically, mutations in TCF4, identified through genomic sequencing efforts of colorectal cancers, appear to be inactivating by compromising its ability to repress cell growth (Sjoblom et al. 2006; Tang et al. 2008).”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“PKM2 has received considerable attention lately, although mainly because of a renewed interest in the role of metabolism and aerobic glycolysis in cancer (Christofk et al. 2008).”
BackgroundThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“Ultimately, the TCF transcription factors that associated with b-catenin completed the understanding of a basic signaling pathway that could account for the potent tumori- genic effects of Wnt (reviewed by Klaus and Birchmeier 2008).”
Backgroundvan Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543 · cited 1×
“The impact of Notch in the intestine was consistent with previous work showing that its activation or inhibition increased or decreased the population of proliferating/progenitor cells, respectively, at the expense of the differentiated population (Fre et al. 2005; van Es et al. 2005).”
ResultMorin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“Granulocyticmacrophage progenitors isolated from CML patients show attributes of excessive Wnt signaling relative to normal progenitors and the introduction of the Wnt pathway inhibitor Axin decreased their capacity for proliferation and self-renewal (Jamieson et al. 2004).”
Background
Cited by
Items 801–859 of 859
Transcription Factors in Cancer
Alsiary, R., Albukhari, T. A., & Filimban, W. A. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080384123010010
Development of the Avian Respiratory System
Maina, J. N. (2023) · Zoological monographs · doi:10.1007/978-3-031-35180-8_2
Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment
Banerjee, P. P., & Srivastava, S. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-2196-6_24-1
Ляшенко, И. С., Romanova, M. V., Гончарова, А. С., Shatova, Y. S., Duritskiy, M. N., & Pozdnyakova, V. V. (2023) · Современные проблемы науки и образования · doi:10.17513/spno.33011
Liu, Z., Shang, C., Wang, J., Gai, Z.-G., Ma, F.-C., Xia, P., Wang, Y., Yang, X., & Zhu, H. (2024) · medRxiv · doi:10.1101/2024.07.02.24309861
Androgen Receptor Signaling: A Central and Evolving Theme in Prostate Cancer Treatment
Banerjee, P. P., & Srivastava, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_24 · Cited by 1
Liu, B., Ong, H. S., Tian, Z., Zhu, L., & Liang, J. F. (2024) · Springer eBooks · doi:10.1007/978-981-97-4155-7_8
Midkine for the Diagnosis and Treatment of Cancer: A Cytokine and a Growth Factor
Ergüven, M. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_138-1
Histopathological Evaluation of PYGO2 Expression in Esophageal Squamous Cell Carcinoma
Khales, S. A., kalat, H. R., Soleymani, S., Jafarian, A. H., & Forghanifard, M. M. (2024) · Iranian journal of pathology · doi:10.30699/ijp.2024.2024609.3269
β2-Chimaerin Deficiency Favors Polyp Growth in the Colon of ApcMin/+ Mice
Velasco, E. A., Sánchez-Vicente, C., & Caloca, M. J. (2025) · Molecules · doi:10.3390/molecules30040824
“APC mutation leads to enhanced Wnt signaling, a key driver of CRC development [4].”
Deciphering WNT Signalling Vulnerabilities in Soft Tissue Sarcoma
Pérez-Capó, M., Martinez-Font, E., Prados, E., Ramos, R., Morillas, R. S., Martorell, M. R., Vögler, O., Alemany, R., & Obrador‐Hevia, A. (2025) · Pathobiology · doi:10.1159/000544933
“Aberrant activation of this pathway has been linked to cancer initiation and progression [13 – 15].”
Role and Therapeutic Implication of Wnt Signalling Pathway in Cancer
Aga, S. S., Nissar, S., & Banday, M. Z. (2025) · Springer eBooks · doi:10.1007/978-981-96-2763-9_7 · Cited by 1
Molecular Alterations in Thyroid Tumors
Ghossein, R., Xu, B., Barletta, J. A., & Tallini, G. (2025) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477633-02
Midkine for the Diagnosis and Treatment of Cancer: A Cytokine and a Growth Factor
Ergüven, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-00763-6_138
Research Progress of LEF1 Gene in Malignant Tumors
Zhao, Y., Pan, C., Yang, S., Xiao-ling, M., Yao, Y., Li, Z., Ma, Q., Wang, X., Wang, C., & Nie, Z. (2025) · Clinical Medicine Insights Oncology · doi:10.1177/11795549251371111
“50,51 Wnt pathway dysregulation is caused by mutations in APC and other components including β -catenin, Axin, or Ring Finger Protein 43 (RNF43) in most sporadic colorectal tumors.”
Wu, J., Wang, Z.-X., Chen, J., Zhong, H., & Yang, G.-J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117441
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600155
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600125
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600161
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600158
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600164
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600131
Hao, M., Jiang, H., Zhao, Y., Li, C., & Jiang, J. (2024) · Figshare · doi:10.6084/m9.figshare.25464883
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600146
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600128
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600143
Liu, S., Harmston, N., Glaser, T. L., Wong, Y., Zhong, Z., Madan, B., Virshup, D. M., & Petretto, E. G. (2020) · Figshare · doi:10.6084/m9.figshare.13141888
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600140
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600134
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600152
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600167
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600149
Liu, X., Jiang, L., Zhang, W., Zhang, J., Luan, X., 詹渊博, Wang, T., Da, J., Liu, L., Zhang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26600170
PRKD1/EIF5A/β-catenin axis inhibits tumorigenesis and metastasis in non-small-cell lung cancer
Wang, Y., Zhang, M., Fang, L., Qu, J., Huo, C., Li, R., Yao, J., & Qu, Y. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02068-9
“…for complex cellular behavior, mediating cell proliferation, differentiation, cell motility, stem cell activity and tissue homeostasis [38 – 40]. β-catenin is a key component of the canonical Wnt signaling and its aberrant activation has been tightly connected to the occurrence and…”
Rôle de la voie de signalisation Hippo dans le développement des ostéosarcomes
Morice, S. (2019) · theses.fr (ABES) · doi:10.70675/32829b80z5982z4f52z949bz98b3ed38b7c0
Kasperek, A. (2021) · theses.fr (ABES) · doi:10.70675/f96fee43zb045z4ccfzb58ez3d30fdfae1d4
Identification of therapeutic targets of nucleolin-related pathways in pancreatic cancer therapy
Raineri, F. (2020) · theses.fr (ABES) · doi:10.70675/b0a30a01z777cz4da7z90cbz3e9a95dd1630
Béguin, A. (2024) · theses.fr (ABES) · doi:10.70675/91026eb5zf996z44a3zad54z8065cd33958b
Liu, X., Qin, L., & Yang, H. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120162
Puxeddu, M., Cui, Z., Colla, C., Nalli, M., Manetto, S., Ciogli, A., Cuřínová, P., Bufano, M., Toto, A., Gianni, S., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00706
“12 The DVL protein family comprises three paralogues (DVL1, 2, and 3), sharing 59 − 67% amino acid (aa) sequence identity 13 and characterized by three highly conserved domains in humans and mice: (i) the 82 − 85 aa N -terminal DIX (Dishevelled − Axin) domain, which promotes DVL oligomerization and…”
Dong, L., Yang, Z., Xu, Z., Huang, G., Yang, X., Lv, Y., Huang, K., Liu, Z., Zhang, F., Jiang, K., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09077-2
Kumar, A. S., Tynninen, O., & Korja, M. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04393-1
Sharath, N. S., Dash, B. R., Arunsi, K., Rashmi, M., Kumar, S., Behera, S. K., & Misra, R. (2026) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2026.101750
DNV-TC: a developmental network vulnerability-based classification system for precision oncology
Toncheva, D., & Sgurev, V. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1780827
“The Wnt-beta-catenin pathway is hyperactivated in colorectal cancer, hepatocellular carcinoma, and medulloblastoma (Polakis, 2012).”
Li, F., & Xi-dai, L. (2026) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v34.i9.714
BindingDB (2026) · UC San Diego · doi:10.7270/q2j38zf2
BindingDB (2021) · UC San Diego · doi:10.7270/q2mg7svd
BindingDB (2020) · UC San Diego · doi:10.7270/q2f76g3g
Transcriptional Regulation of Dendritic Cells in the Tumor Microenvironment
Jiang, A., Stagliano, K. E., Cuss, S. M., Triplett, A., Fu, C., & Hurwitz, A. A. (2014) · Springer eBooks · doi:10.1007/978-1-4899-8056-4_9
“As a result, mutations or dysregulation of components of the Wnt signaling pathway have been linked to a wide range of human diseases including cancer [143].”
BackgroundDevelopmental Signaling Requires Inwardly Rectifying K+ Channels in Drosophila melanogaster
Dahal, G. R. (2013) · ScholarsArchive (Brigham Young University)
Wnt/Frizzled Signaling in the Vasculature
Couffinhal, T., Dufourcq, P., & Duplàa, C. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0466-8_4
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, P.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-03-20
- Volume
- 4
- Issue
- 5
- Pages
- a008052-a008052
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC3331705
- OpenAlex
- W2149598894
- Cited by
- 847
- References
- 94
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 41 · 2023: 36 · 2022: 56 · 2021: 85 · 2020: 76 · 2019: 77 · 2018: 76 · 2017: 95 · 2016: 89 · 2015: 64 · 2014: 54 · 2013: 51 · 2012: 13
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt signaling, cancer, epigenetic regulation, Wnt inhibitors, malignant transformation, tumor genome sequencing
- MeSH terms
- Humans, Models, Biological, Mutation, Neoplasms, Oncogene Proteins, Tumor Suppressor Proteins, Epigenesis, Genetic, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.